Enriched Variations in TEKT4 and Breast Cancer Resistance to Paclitaxel

Nature Communications - United Kingdom
doi 10.1038/ncomms4802
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Aurora Kinase a Stabilizes FOXM1 to Enhance Paclitaxel Resistance in Triple‐negative Breast Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Estrogen Receptor Mediates Breast Cancer Cell Resistance to Paclitaxel Through Inhibition of Apoptotic Cell Death

Cancer Research
Cancer ResearchOncology
2007English

Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol)

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2005English

Downregulation of miR‑200c‑3p Contributes to the Resistance of Breast Cancer Cells to Paclitaxel by Targeting SOX2

Oncology Reports
MedicineCancer ResearchOncology
2018English

Different Administration Strategies With Paclitaxel Induce Distinct Phenotypes of Multidrug Resistance in Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2013English

P092 Apatinib Reverses Paclitaxel Resistance in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Suppression of DUSP5 Expression Correlates With Paclitaxel Resistance and Poor Prognosis in Basal-Like Breast Cancer

International Journal of Medical Sciences
Medicine
2018English

BRCA1-IRIS Inactivation Overcomes Paclitaxel Resistance in Triple Negative Breast Cancers

Breast Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy